Lisa von Moltke, former acting senior VP and head of clinical development at US global biotechnology company Alkermes, has moved to Seres Therapeutics as CMO. The Boston-headquartered biotechnology company Seres focuses on drugs to treat infectious, metabolic, and inflammatory diseases by targeting the underlying biology of the human microbiome.
Since the dawn of the 20th century, there has been a huge change in the career opportunities available to women. Although still generally outnumbered by men, it is an everyday experience to learn of female doctors, lawyers, politicians, academics, architects, priests, engineers, scientists etc
Climate change and global warming are two sides of the same coin since both trace their origins to the release of huge amounts of polluting gases from the burning of fossil fuels. The gases most often headlined in the global warming context are carbon dioxide, methane and some of the oxides of nitrogen.
The coronavirus pandemic has focused attention on deep cleaning, especially long-lasting hard surface cleaners. But other cleaning product research is also looking at using probiotics and reducing water and energy usage. Neil Eisberg reports
Will the Covid-19 pandemic bring about major global changes? Many people are asking this question with regard to everything from working practices, for example, is the day of the office building over as a result of IT, through to the potential end of fossil fuel usage for transportation and energy generation.
Air pollution kills 1.25m people in India every year. India’s capital New Delhi has the worst air pollution of any capital city. However, air pollution has dropped dramatically as a result of lockdown to control coronavirus.
New technology makes it easier for researchers to observe and manipulate individual atoms and molecules as they engage in fundamental processes like the making and breaking of chemical bonds. Michael Gross reports
Light driven molecular motors possess immense potential as central driving units for future nanotechnology. Integration into larger molecular setups and transduction of their mechanical motions represents the current frontier of research.
One of the dirty secrets of medical chemistry is the naughty over-simplification of primary assays leading to erroneous interpretations of data from them. In a milestone study, Rubin and co-workers, from UC Santa Cruz, UC San Francisco, and Roswell Park, NY, have exposed one of these skeletons in the closet (Science, 2019, 366, 1330).
US-headquartered gene therapy company Asklepios BioPharmaceutical has acquired Paris-based gene therapy company BrainVectis, a spin out from the French National Institute for Health and Medical Research.